{"id":8729,"date":"2025-11-11T10:50:26","date_gmt":"2025-11-11T09:50:26","guid":{"rendered":"https:\/\/ekfz.uni-goettingen.de\/mitteilungen\/8729\/"},"modified":"2026-01-08T11:39:05","modified_gmt":"2026-01-08T10:39:05","slug":"8729","status":"publish","type":"cdp_press_release","link":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/","title":{"rendered":"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ"},"content":{"rendered":"<p>Degenerative retinal diseases such as Retinitis pigmentosa (RP) and geographic atrophy (GA) affect approximately 10 million people worldwide and lead to significant and often irreversible vision loss.<br \/>\n<strong>Note: <span style=\"color: #004a94;\">The prospective observational study began in March 2025 and is designed for five years (Clinical-Trials.gov ID: NCT07056738). Interested study participants can still register. <\/span><\/strong><\/p>\n","protected":false},"featured_media":0,"template":"","cdp_year":[155],"class_list":["post-8729","cdp_press_release","type-cdp_press_release","status-publish","hentry","cdp_year-2025-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz\" \/>\n<meta property=\"og:description\" content=\"Degenerative retinal diseases such as Retinitis pigmentosa (RP) and geographic atrophy (GA) affect approximately 10 million people worldwide and lead to significant...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/\" \/>\n<meta property=\"og:site_name\" content=\"ekfz\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-08T10:39:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/\",\"url\":\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/\",\"name\":\"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz\",\"isPartOf\":{\"@id\":\"https:\/\/ekfz.uni-goettingen.de\/en\/#website\"},\"datePublished\":\"2025-11-11T09:50:26+00:00\",\"dateModified\":\"2026-01-08T10:39:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/ekfz.uni-goettingen.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ekfz.uni-goettingen.de\/en\/#website\",\"url\":\"https:\/\/ekfz.uni-goettingen.de\/en\/\",\"name\":\"ekfz\",\"description\":\"Else Kr\u00f6ner Fresenius Zentrum f\u00fcr Optogenetische Therapien\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ekfz.uni-goettingen.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/","og_locale":"en_US","og_type":"article","og_title":"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz","og_description":"Degenerative retinal diseases such as Retinitis pigmentosa (RP) and geographic atrophy (GA) affect approximately 10 million people worldwide and lead to significant...","og_url":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/","og_site_name":"ekfz","article_modified_time":"2026-01-08T10:39:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/","url":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/","name":"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ - ekfz","isPartOf":{"@id":"https:\/\/ekfz.uni-goettingen.de\/en\/#website"},"datePublished":"2025-11-11T09:50:26+00:00","dateModified":"2026-01-08T10:39:05+00:00","breadcrumb":{"@id":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ekfz.uni-goettingen.de\/en\/mitteilungen\/8729\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/ekfz.uni-goettingen.de\/en\/"},{"@type":"ListItem","position":2,"name":"Optimization of a Ganglion Cell-Based Optogenetic Therapy for Vision Restoration \u2013 Study by the EKFZ"}]},{"@type":"WebSite","@id":"https:\/\/ekfz.uni-goettingen.de\/en\/#website","url":"https:\/\/ekfz.uni-goettingen.de\/en\/","name":"ekfz","description":"Else Kr\u00f6ner Fresenius Zentrum f\u00fcr Optogenetische Therapien","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ekfz.uni-goettingen.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/ekfz.uni-goettingen.de\/en\/wp-json\/wp\/v2\/cdp_press_release\/8729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekfz.uni-goettingen.de\/en\/wp-json\/wp\/v2\/cdp_press_release"}],"about":[{"href":"https:\/\/ekfz.uni-goettingen.de\/en\/wp-json\/wp\/v2\/types\/cdp_press_release"}],"wp:attachment":[{"href":"https:\/\/ekfz.uni-goettingen.de\/en\/wp-json\/wp\/v2\/media?parent=8729"}],"wp:term":[{"taxonomy":"cdp_year","embeddable":true,"href":"https:\/\/ekfz.uni-goettingen.de\/en\/wp-json\/wp\/v2\/cdp_year?post=8729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}